CSIMarket
 


Acutus Medical Inc   (AFIB)
Other Ticker:  
 

Acutus Medical Inc 's Leverage Ratio

AFIB's quarterly Leverage Ratio and Total Liabilities, Equity growth


In Spite of the repayements of liabilities of -6.25%, in III Quarter 2023 ,Leverage Ratio deteriorated to 1.67 reached a new all-time high.

Within Medical Equipment & Supplies industry in the third quarter 2023, 148 other companies have achieved lower Leverage Ratio than Acutus Medical Inc in the III Quarter 2023. While Leverage Ratio total ranking has deteriorated compared to the second quarter 2023 from 2102 to 2396 .

Explain Leverage Ratio?
Who are AFIB Customers?
What are AFIB´s Total Liabilities?


AFIB Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change -45.13 % -42.93 % -12.06 % -29.04 % -56.78 %
Y / Y Total Liabilities Change -6.73 % -8.31 % -11.69 % -8.81 % -10.81 %
Leverage Ratio MRQ 1.67 1.29 0.92 0.78 0.98
AFIB's Total Ranking # 2396 # 2102 # 1530 # 1329 # 1859
Seq. Equity Change -27.51 % -27.66 % -19.4 % 29.83 % -24.62 %
Seq. Total Liabilities Change -6.25 % 1.84 % -4.95 % 2.77 % -7.84 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 699
Overall Market # 2396


Leverage Ratio Statistics
High Average Low
1.67 0.83 0.39
(Sep 30 2023)   (Sep 30 2020)




Financial Statements
Acutus Medical Inc 's Equity $ 32 Millions Visit AFIB's Balance sheet
Acutus Medical Inc 's Total Liabilities $ 53 Millions Visit AFIB's Balance sheet
Source of AFIB's Sales Visit AFIB's Sales by Geography


Cumulative Acutus Medical Inc 's Leverage Ratio

AFIB's Leverage Ratio for the trailling 12 Months

AFIB Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth -45.13 % -42.93 % -12.06 % -29.04 % -56.78 %
Y / Y Total Liabilities TTM Growth -6.73 % -8.31 % -11.69 % -8.81 % -10.81 %
Leverage Ratio TTM 1.06 0.96 0.86 0.86 0.79
Total Ranking TTM # 2376 # 7 # 89 # 1053 # 1550
Seq. Equity TTM Growth -27.51 % -27.66 % -19.4 % 29.83 % -24.62 %
Seq. Total Liabilities TTM Growth -6.25 % 1.84 % -4.95 % 2.77 % -7.84 %


On the trailing twelve months basis Despite of the repayements of liabilities of -6.25% in the trailing twelve months ending in III Quarter 2023, Leverage Ratio improved to 1.06, below Acutus Medical Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 149, during the past 12 months, other companies have achieved lower Leverage Ratio than Acutus Medical Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 7 to 2376.

Explain Leverage Ratio?
Who are AFIB Customers?
What are AFIB´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 150
Healthcare Sector # 703
Within the Market # 2376


trailing twelve months Leverage Ratio Statistics
High Average Low
5.76 1.56 0.49
(Dec 31 2020)   (Sep 30 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
Owens and Minor inc  4.47 $ 3,966.379  Millions$ 886.860  Millions
Transmedics Group Inc   4.39 $ 554.535  Millions$ 126.460  Millions
Plus Therapeutics Inc   3.97 $ 10.421  Millions$ 2.622  Millions
Yunhong Green Cti Ltd   3.88 $ 11.345  Millions$ 2.926  Millions
P3 Health Partners Inc   3.77 $ 708.949  Millions$ 187.943  Millions
Envoy Medical Inc   3.43 $ 16.429  Millions$ 4.786  Millions
Cerus Corporation  3.27 $ 157.676  Millions$ 48.168  Millions
Petvivo Holdings Inc  3.11 $ 3.073  Millions$ 0.989  Millions
Insulet Corporation  3.06 $ 1,860.200  Millions$ 607.500  Millions
Trisalus Life Sciences Inc   2.95 $ 25.067  Millions$ 8.487  Millions
Carmell Corporation  2.93 $ 61.306  Millions$ 20.918  Millions
Bioventus Inc   2.80 $ 633.575  Millions$ 226.456  Millions
The Pennant Group Inc   2.77 $ 385.792  Millions$ 139.519  Millions
Baxter International Inc   2.76 $ 22,555.000  Millions$ 8,166.000  Millions
Uphealth Inc   2.67 $ 171.014  Millions$ 64.130  Millions
Minerva Surgical Inc   2.40 $ 48.513  Millions$ 20.255  Millions
Helius Medical Technologies inc   1.93 $ 5.833  Millions$ 3.021  Millions
Strata Skin Sciences Inc   1.91 $ 31.000  Millions$ 16.193  Millions
Tenon Medical Inc   1.91 $ 4.801  Millions$ 2.517  Millions
Iridex Corp  1.90 $ 22.885  Millions$ 12.064  Millions
Dexcom Inc   1.86 $ 4,214.900  Millions$ 2,267.900  Millions
Tela Bio Inc   1.86 $ 56.765  Millions$ 30.552  Millions
Artivion Inc   1.85 $ 502.812  Millions$ 271.975  Millions
Conmed Corporation  1.84 $ 1,462.557  Millions$ 796.205  Millions
Vaso Corporation  1.76 $ 45.011  Millions$ 25.609  Millions
Soleno Therapeutics Inc  1.74 $ 40.328  Millions$ 23.220  Millions
Novocure Limited  1.71 $ 675.156  Millions$ 393.704  Millions
Acutus Medical Inc   1.67 $ 53.022  Millions$ 31.706  Millions
Patterson Companies Inc   1.67 $ 1,761.001  Millions$ 1,055.089  Millions
Escalon Medical Corp   1.58 $ 3.015  Millions$ 1.914  Millions

Date modified: 2023-11-17T15:08:52+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com